This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (29)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Depression  • Alert me on articles by topic  Social Bookmarking   What's this?

Hans-Peter Landolt, PhD; Eric B. Raimo, MD; Bradley J. Schnierow, MD; John R. Kelsoe, MD; Mark H. Rapaport, MD; J. Christian Gillin, MD

Arch Gen Psychiatry. 2001;58:268-276.

Background  The beneficial effect of antidepressant interventions has been proposed to depend on suppression of rapid eye movement (REM) sleep or inhibition of electroencephalographic (EEG) slow-wave activity (SWA) in non-REM sleep. Use of the monoamine oxidase inhibitor phenelzine sulfate can eliminate REM sleep. We studied the relation between REM sleep suppression and antidepressant response and the effect of phenelzine therapy on sleep EEG power spectra.

Methods  Open-labeled prescriptions of 30 to 90 mg of phenelzine were given to 11 patients with major depressive disorder (6 men and 5 women; mean age, 41.4 years); all were physically healthy. Mood, dream recall, sleep, sleep EEG, and ocular and muscular activity during sleep were studied before treatment and during the third and fifth weeks of pharmacotherapy.

Results  Six patients remitted from depression, 2 responded partially, and 3 showed no antidepressant response. Independent from clinical response, REM sleep was dramatically suppressed. On average, only 4.9 minutes of REM sleep was observed in treatment week 5, and it was completely absent in 6 patients. This effect was compensated for by increased stage 2 sleep. In non-REM sleep, EEG power was higher than at baseline between 16.25 and 25 Hz. Slow-wave activity (power within 0.75-4.5 Hz) and the exponential decline of SWA during sleep were not affected.

Conclusions  Antidepressant response to phenelzine treatment does not depend on elimination of REM sleep or inhibition of SWA in non-REM sleep. In depressed patients, REM sleep is regulated independently from non-REM sleep and can be manipulated without altering the dynamics of SWA.

From the Department of Psychiatry, University of California at San Diego, Veterans Affairs San Diego Healthcare System, San Diego.

Corresponding author and reprints: Hans-Peter Landolt, PhD, c/o J. Christian Gillin, MD, University of California at San Diego, Mental Health Clinical Research Center, Psychiatry Service (116-A), Veterans Affairs Medical Center, 3350 La Jolla Village Dr, San Diego, CA 92161 (e-mail: landolt{at}pharma.unizh.ch).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Associations of a Regulatory Polymorphism of Monoamine Oxidase-A Gene Promoter (MAOA-uVNTR) With Symptoms of Depression and Sleep Quality
Brummett et al.
Psychosom. Med. 2007;69:396-401.
ABSTRACT | FULL TEXT  

Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease
Landolt et al.
Neurology 2006;66:1418-1424.
ABSTRACT | FULL TEXT  

REM Sleep Effects as a Biomarker for the Effects of Antidepressants in Healthy Volunteers
Rijnbeek et al.
J Psychopharmacol 2003;17:196-203.
ABSTRACT  

Selective REM sleep deprivation during daytime: I. Time course of interventions and recovery sleep
Werth et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002;283:R521-R526.
ABSTRACT | FULL TEXT  

Selective REM sleep deprivation during daytime: II. Muscle atonia in non-REM sleep
Werth et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002;283:R527-R532.
ABSTRACT | FULL TEXT